Three consecutive commercial-scale drug product batches successfully produced Supports potential sozinibercept BLA filing in 1H CY2026 MELBOURNE, ...
Retinal gene therapy advancements may rewrite the book on treatments for age-related macular degeneration and diabetic eye diseases.
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
20h
Hosted on MSNHMC enhances diabetes care with comprehensive servicesHanane DjouaDohaHamad Medical Corporation (HMC) continues to set new benchmarks in diabetes management through its National Diabetes Centers, which provide cutting-edge treatments, patient education, ...
1h
ZME Science on MSNDoctors Restore Sight in Blind Children with Groundbreaking Gene TherapyA single injection of a healthy gene allowed blind children to recognize objects, shapes, and even read — offering hope for ...
Last year marked an all-time record of 18 Food and Drug Administration (FDA) biosimilar approvals, bringing the total number ...
PASADENA, CA, USA I February 25, 2025 I Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced preclinical results on ARO-ALK7, the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results